These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8269798)

  • 1. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.
    Giugliano D; De Rosa N; Di Maro G; Marfella R; Acampora R; Buoninconti R; D'Onofrio F
    Diabetes Care; 1993 Oct; 16(10):1387-90. PubMed ID: 8269798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
    Dorella M; Giusto M; Da Tos V; Campagnolo M; Palatini P; Rossi G; Ceolotto G; Felice M; Semplicini A; Del Prato S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1568-74. PubMed ID: 8636369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes.
    Marena S; Tagliaferro V; Montegrosso G; Pagano A; Scaglione L; Pagano G
    Diabete Metab; 1994; 20(1):15-9. PubMed ID: 8056129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of acarbose on insulin resistance in obese hypertensive subjects with normal glucose tolerance: a randomized controlled study.
    Rachmani R; Bar-Dayan Y; Ronen Z; Levi Z; Slavachevsky I; Ravid M
    Diabetes Obes Metab; 2004 Jan; 6(1):63-8. PubMed ID: 14686965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and metoprolol CR treatment in non-obese men.
    Landin K; Tengborn L; Smith U
    J Intern Med; 1994 Apr; 235(4):335-41. PubMed ID: 8151265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.
    Gudbjörnsdottir S; Friberg P; Elam M; Attvall S; Lönnroth P; Wallin BG
    Blood Press; 1994 Nov; 3(6):394-403. PubMed ID: 7704288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors.
    Landin K; Tengborn L; Smith U
    J Intern Med; 1991 Feb; 229(2):181-7. PubMed ID: 1900072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
    Herrmann BL; Berg C; Vogel E; Nowak T; Renzing-Koehler K; Mann K; Saller B
    Horm Metab Res; 2004 Jan; 36(1):54-61. PubMed ID: 14983408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial.
    He H; Zhao Z; Chen J; Ni Y; Zhong J; Yan Z; Li Y; Liu D; Pletcher MJ; Zhu Z
    J Hypertens; 2012 Jul; 30(7):1430-9. PubMed ID: 22525206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.
    Fritsche A; Schmülling RM; Häring HU; Stumvoll M
    Acta Diabetol; 2000 Mar; 37(1):13-8. PubMed ID: 10928231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patients.
    Snorgaard O; Køber L; Carlsen J
    J Intern Med; 1997 Nov; 242(5):407-12. PubMed ID: 9408071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
    Miyazaki Y; Mahankali A; Matsuda M; Glass L; Mahankali S; Ferrannini E; Cusi K; Mandarino LJ; DeFronzo RA
    Diabetes Care; 2001 Apr; 24(4):710-9. PubMed ID: 11315836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients.
    Bogdanski P; Suliburska J; Szulinska M; Stepien M; Pupek-Musialik D; Jablecka A
    Nutr Res; 2012 Jun; 32(6):421-7. PubMed ID: 22749178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
    Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased level of hemoglobin A1c, but not impaired insulin sensitivity, found in hypertensive and normotensive smokers.
    Nilsson PM; Lind L; Pollare T; Berne C; Lithell HO
    Metabolism; 1995 May; 44(5):557-61. PubMed ID: 7752901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term glycaemic improvement after addition of metformin to insulin in insulin-treated obese type 2 diabetes patients.
    Hermann LS; Kalén J; Katzman P; Lager I; Nilsson A; Norrhamn O; Sartor G; Ugander L
    Diabetes Obes Metab; 2001 Dec; 3(6):428-34. PubMed ID: 11903415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
    Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.